Open AccessEfficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury
Author(s) -
Michael A. Puskarich,
Nicholas E. Ingraham,
Lisa H. Merck,
Brian E. Driver,
David A. Wacker,
Lauren Page Black,
Alan E. Jones,
Courtney V. Fletcher,
Andrew M. South,
Thomas A. Murray,
Christopher Lewandowski,
Joseph Farhat,
Justin L. Benoit,
Michelle H. Biros,
Kartikeya Cherabuddi,
Jeffrey G. Chipman,
Timothy W. Schacker,
Faheem W. Guirgis,
Helen Voelker,
Joseph S. Koopmeiners,
Christopher J. Tignanelli,
Andrew C. Nelson,
Alex Hall,
David W. Wright,
Ronald A. Reilkoff,
Tyler D. Bold,
Kenneth B. Beckman,
Ryan A. Langlois,
Matthew T. Aliota,
James Galbriath,
Margaret Beyer,
Chas R. Salmen,
Dana Byrne,
Brian W. Roberts,
Nastasia James
Publication year - 2022
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2022.2735
Subject(s) - losartan , medicine , placebo , angiotensin ii , randomized controlled trial , anesthesia , blood pressure , pathology , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom